Lannett (LCI) – Lawsuits Will Wipe Out The Equity" Citron Research
Lannett will be the First Pharma Company to go Bankrupt amid Continuing Drug Pricing Scrutiny
If Even Modest Price Cuts Hit Either of Lannett’s Cash Cow Drugs, It Will Violate Its Debt CovenantsÂ
$13-$15 Near Term Target
Equity Worthless Over Long-Term
Over the past year, almost every media outlet in the US has dissected the pharmaceutical industry to expose the culprits of rampant opportunistically driven price gouging. We . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.
|
